Similar articles for PMID: 31242394

Year	Number of Results
2008	1
2009	2
2010	2
2011	2
2012	1
2013	5
2014	4
2015	12
2016	17
2017	16
2018	21
2019	18
2020	3
2021	1
2022	1
2024	0

1

Mobile Health Monitoring in Patients with Idiopathic Pulmonary Fibrosis.

Marcoux V, Wang M, Burgoyne SJ, Fell CD, Ryerson CJ, Sajobi TT, Johannson KA. Marcoux V, et al. Ann Am Thorac Soc. 2019 Oct;16(10):1327-1329. doi: 10.1513/AnnalsATS.201904-335RL. Ann Am Thorac Soc. 2019. PMID: 31242394 No abstract available.

2

Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.

Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts JGJV, Chavannes NH, Wijsenbeek MS. Moor CC, et al. Am J Respir Crit Care Med. 2020 Aug 1;202(3):393-401. doi: 10.1164/rccm.202002-0328OC. Am J Respir Crit Care Med. 2020. PMID: 32325005 Clinical Trial.

3

A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.

Moor CC, Wapenaar M, Miedema JR, Geelhoed JJM, Chandoesing PP, Wijsenbeek MS. Moor CC, et al. Respir Res. 2018 May 29;19(1):105. doi: 10.1186/s12931-018-0810-3. Respir Res. 2018. PMID: 29843728 Free PMC article.

4

Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.

Johannson KA, Vittinghoff E, Morisset J, Lee JS, Balmes JR, Collard HR. Johannson KA, et al. Eur Respir J. 2017 Jul 5;50(1):1602406. doi: 10.1183/13993003.02406-2016. Print 2017 Jul. Eur Respir J. 2017. PMID: 28679608 Free PMC article.

5

Lung function testing in idiopathic pulmonary fibrosis: More than just spirometry?

Casan Clarà P, Martínez González C, Ancochea J. Casan Clarà P, et al. Arch Bronconeumol. 2016 Sep;52(9):457-8. doi: 10.1016/j.arbres.2016.02.017. Epub 2016 Apr 14. Arch Bronconeumol. 2016. PMID: 27087238 English, Spanish. No abstract available.

6

FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change.

Nathan SD, Yang M, Morgenthien EA, Stauffer JL. Nathan SD, et al. Eur Respir J. 2020 May 14;55(5):1902151. doi: 10.1183/13993003.02151-2019. Print 2020 May. Eur Respir J. 2020. PMID: 32029447 Free PMC article.

7

Physiological Profile and Limitations in Exercise in Idiopathic Pulmonary Fibrosis.

Vainshelboim B, Oliveira J, Fox BD, Adir Y, Ollech JE, Kramer MR. Vainshelboim B, et al. J Cardiopulm Rehabil Prev. 2016 Jul-Aug;36(4):270-8. doi: 10.1097/HCR.0000000000000177. J Cardiopulm Rehabil Prev. 2016. PMID: 27120038

8

Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosis.

Arizono S, Taniguchi H, Sakamoto K, Kondoh Y, Kimura T, Kataoka K, Ogawa T, Watanabe F, Nishiyama O, Nishimura K, Kozu R, Tabira K. Arizono S, et al. Respir Care. 2014 Jul;59(7):1108-15. doi: 10.4187/respcare.02674. Epub 2013 Dec 10. Respir Care. 2014. PMID: 24327743 Free article.

9

Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A CASE REPORT.

Perrotta F, Bianco A, Cioffi G, Cennamo A, Mazzarella G. Perrotta F, et al. J Cardiopulm Rehabil Prev. 2018 Sep;38(5):E16-E18. doi: 10.1097/HCR.0000000000000319. J Cardiopulm Rehabil Prev. 2018. PMID: 29672359

10

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.

Glassberg MK, Minkiewicz J, Toonkel RL, Simonet ES, Rubio GA, DiFede D, Shafazand S, Khan A, Pujol MV, LaRussa VF, Lancaster LH, Rosen GD, Fishman J, Mageto YN, Mendizabal A, Hare JM. Glassberg MK, et al. Chest. 2017 May;151(5):971-981. doi: 10.1016/j.chest.2016.10.061. Epub 2016 Nov 24. Chest. 2017. PMID: 27890713 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year